They also have excellent safety profile and lead to benefits independent of weight loss. For patients with diabetes, there have been studies showing that medical providers are less likely to prescribe certain medications to commercially insured patients who are Black, than they are to those who are white
Any licensed health care providerincluding primary care physicians, nurse practitioners, physician assistants, and specialists such as endocrinologists, cardiologists, and gastroenterologistscan prescribe GLP-1 medications
However, limited or no medical nutrition therapy (MNT) guidelines are provided to healthcare providers and patients regarding adequate nutrient intake during GLP-1RA use
Total net spending on obesity drugs is forecasted to increase 378% between 2023 and 2027 and includes the launch of 2-5 novel GLP-1 and GLP-1/GIP combination drugs
Journal reference: Martinelli, S., Mazzotta, A., Longaroni, M., & Petrucciani, N
Johns Hopkins Bloomberg School of Public Health
